Literature DB >> 21387846

The effects of particle size, density and shape on margination of nanoparticles in microcirculation.

Randall Toy1, Elliott Hayden, Christopher Shoup, Harihara Baskaran, Efstathios Karathanasis.   

Abstract

In the recent past, remarkable advances in nanotechnology have generated nanoparticles of different shapes and sizes, which have been shown to exhibit unique properties suitable for biomedical applications such as cancer therapy and imaging. Obviously, all nanoparticles are not made equal. This becomes evident when we consider their transport behavior under blood flow in microcirculation. In this work, we evaluated the effect of critical physical characteristics such as the particle shape, size and density on a nanoparticle's tendency to marginate towards the vessel walls in microcirculation using an in vitro model. The wall deposition of nanoparticles was tested in a fibronectin-coated microfluidic channel at a physiologically relevant flow rate. Different classes of nanoparticles (liposome, metal particles) of different sizes (60-130 nm), densities (1-19 g ml(-1)) and shapes (sphere, rod) displayed significantly different deposition as a result of different margination rates. The smaller-sized and the oblate-shaped particles displayed a favorable behavior as indicated by their higher margination rates. Notably, the particle density showed an even more essential role, as it was observed that the lighter particles marginated significantly more. Since nanoparticles must escape the flow in order to approach the vascular bed and subsequently extravascular components for meaningful interactions, the design of nanoparticles strongly affects their margination, a key factor for their ultimate in vivo effectiveness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21387846      PMCID: PMC3530262          DOI: 10.1088/0957-4484/22/11/115101

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  36 in total

1.  Materials and biology. Nanotechnology takes aim at cancer.

Authors:  Robert F Service
Journal:  Science       Date:  2005-11-18       Impact factor: 47.728

Review 2.  Fibronectin at a glance.

Authors:  Roumen Pankov; Kenneth M Yamada
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

3.  Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging.

Authors:  Ji-Ho Park; Geoffrey von Maltzahn; Lianglin Zhang; Michael P Schwartz; Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  Adv Mater       Date:  2008-05-05       Impact factor: 30.849

4.  The effective dispersion of nanovectors within the tumor microvasculature.

Authors:  P Decuzzi; F Causa; M Ferrari; P A Netti
Journal:  Ann Biomed Eng       Date:  2006-03-28       Impact factor: 3.934

Review 5.  Liposomal anthracyclines: adjuvant and neoadjuvant therapy for breast cancer.

Authors:  Susana Campos
Journal:  Oncologist       Date:  2003

6.  Chemical and physical modifications to poly(dimethylsiloxane) surfaces affect adhesion of Caco-2 cells.

Authors:  Lin Wang; Bing Sun; Katherine S Ziemer; Gilda A Barabino; Rebecca L Carrier
Journal:  J Biomed Mater Res A       Date:  2010-06-15       Impact factor: 4.396

7.  Fibronectin adsorption studied using neutron reflectometry and complementary techniques.

Authors:  M Al-Jawad; G Fragneto; J Liu; S R Chang; B Clarkson
Journal:  Eur Phys J E Soft Matter       Date:  2009-10       Impact factor: 1.890

8.  Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids.

Authors:  Markus Johnsson; Katarina Edwards
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

9.  The margination propensity of spherical particles for vascular targeting in the microcirculation.

Authors:  Francesco Gentile; Antonio Curcio; Ciro Indolfi; Mauro Ferrari; Paolo Decuzzi
Journal:  J Nanobiotechnology       Date:  2008-08-15       Impact factor: 10.435

10.  Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.

Authors:  Efstathios Karathanasis; Leslie Chan; Lohitash Karumbaiah; Kathleen McNeeley; Carl J D'Orsi; Ananth V Annapragada; Ioannis Sechopoulos; Ravi V Bellamkonda
Journal:  PLoS One       Date:  2009-06-09       Impact factor: 3.240

View more
  61 in total

1.  Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles.

Authors:  Ying Li; Yanping Lian; Lucy T Zhang; Saad M Aldousari; Hassan S Hedia; Saeed A Asiri; Wing Kam Liu
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

Review 2.  Particle margination and its implications on intravenous anticancer drug delivery.

Authors:  Erik Carboni; Katherine Tschudi; Jaewook Nam; Xiuling Lu; Anson W K Ma
Journal:  AAPS PharmSciTech       Date:  2014-04-02       Impact factor: 3.246

Review 3.  Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems.

Authors:  Daniel J Sobczynski; Margaret B Fish; Catherine A Fromen; Mariana Carasco-Teja; Rhima M Coleman; Omolola Eniola-Adefeso
Journal:  Ther Deliv       Date:  2015-08-14

Review 4.  Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine.

Authors:  Amy M Wen; Pooja H Rambhia; Roger H French; Nicole F Steinmetz
Journal:  J Biol Phys       Date:  2013-04-19       Impact factor: 1.365

Review 5.  Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Authors:  Prabhani U Atukorale; Gil Covarrubias; Lisa Bauer; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2016-09-15       Impact factor: 15.470

6.  Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands.

Authors:  P M Peiris; F He; G Covarrubias; S Raghunathan; O Turan; M Lorkowski; B Gnanasambandam; C Wu; W P Schiemann; E Karathanasis
Journal:  Nanoscale       Date:  2018-04-19       Impact factor: 7.790

7.  Direct Tracking of Particles and Quantification of Margination in Blood Flow.

Authors:  Erik J Carboni; Brice H Bognet; Grant M Bouchillon; Andrea L Kadilak; Leslie M Shor; Michael D Ward; Anson W K Ma
Journal:  Biophys J       Date:  2016-10-04       Impact factor: 4.033

8.  Vascular-targeted particle binding efficacy in the presence of rigid red blood cells: Implications for performance in diseased blood.

Authors:  Mario Gutierrez; Lauro Sebastian Ojeda; Omolola Eniola-Adefeso
Journal:  Biomicrofluidics       Date:  2018-06-25       Impact factor: 2.800

Review 9.  Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.

Authors:  William J Kelley; Hanieh Safari; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-19

10.  Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil(®)): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues.

Authors:  Yasmine Amitay; Hilary Shmeeda; Yogita Patil; Jenny Gorin; Dina Tzemach; Lidia Mak; Patricia Ohana; Alberto Gabizon
Journal:  Pharm Res       Date:  2015-11-16       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.